Cancer stem cells in colorectal cancer: Signaling pathways involved in stemness and therapy resistance

Nasim Ebrahimi, Maral Afshinpour, Siavash Seifollahy Fakhr, Paniz Ghasempour Kalkhoran, Vida Shadman-Manesh, Samaneh Adelian, Sheida Beiranvand, Fatemeh Rezaei-Tazangi, Roya Khorram, Michael R. Hamblin, Amir Reza Aref

Research output: Contribution to journalReview articlepeer-review

32 Citations (Scopus)

Abstract

Colorectal cancer (CRC) is the third cause of cancer death worldwide. Although, in some cases, treatment can increase patient survival and reduce cancer recurrence, in many cases, tumors can develop resistance to therapy leading to recurrence. One of the main reasons for recurrence and therapy resistance is the presence of cancer stem cells (CSCs). CSCs possess a self-renewal ability, and their stemness properties lead to the avoidance of apoptosis, and allow a new clone of cancer cells to emerge. Numerous investigations inidicated the involvment of cellular signaling pathways in embryonic development, and growth, repair, and maintenance of tissue homeostasis, also participate in the generation and maintenance of stemness in colorectal CSCs. This review discusses the role of Wnt, NF-κB, PI3K/AKT/mTOR, Sonic hedgehog, and Notch signaling pathways in colorectal CSCs, and the possible modulating drugs that could be used in treatment for resistant CRC.

Original languageEnglish
Article number103920
JournalCritical Reviews in Oncology/Hematology
Volume182
DOIs
Publication statusPublished - Feb 2023

Keywords

  • Cancer initiating cells
  • Cancer stem cells
  • Cellular metabolism
  • Colorectal cancer
  • Drug resistance
  • Signaling pathways

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Cancer stem cells in colorectal cancer: Signaling pathways involved in stemness and therapy resistance'. Together they form a unique fingerprint.

Cite this